Stocksigma LogoStocksigma Logo

Blue Jet Healthcare Reports Strong Q2 FY27 Results Driven by API Intermediates

Blue Jet Healthcare reported revenue from operations of ₹3,757mn in Q2 ended 30th Sep'26, up 127.1% YoY and 28.2% QoQ, driven by a 322% YoY surge in Pharma

Blue Jet Healthcare Reports Strong Q2 FY27 Results Driven by API Intermediates

Blue Jet Healthcare Ltd · Investor Presentation · 05 Nov 2026, 9:34 pm

Blue Jet Healthcare Reports Strong Q2 FY27 Results Driven by API Intermediates Blue Jet Healthcare reported revenue from operations of ₹3,757mn in Q2 ended 30th Sep'26, up 127.1% YoY and 28.2% QoQ, driven by a 322% YoY surge in Pharma Intermediates & APIs and an 80% increase in Contrast Media. EBITDA rose 116.1% YoY to ₹1,188mn (31.6% margin), while PAT climbed 96.6% YoY to ₹1,025mn (27.3% margin). For H1 FY27, revenue reached ₹6,689mn (+28.6% YoY) with PAT of ₹1,808mn. Additionally, its Hyderabad R&D facility became operational, with peptide fragment commercialization slated for Q4 FY27.

Original exchange filing (PDF)

More announcements from Blue Jet Healthcare Ltd

All Blue Jet Healthcare Ltd announcements